Home Newsletters Mesenchymal Cell News Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid...

Neoadjuvant Therapy Induces a Potent Immune Response to Sarcoma, Dominated by Myeloid and B Cells

0
Researchers characterized changes in the soft tissue sarcoma tumor immune microenvironment induced by standard neoadjuvant therapy with the goal of informing neoadjuvant immunotherapy trial design.
[Clinical Cancer Research]
7992332 {7992332:BBBBBBBB} apa 50 1 171504 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Abstract
Exit mobile version